Ranbaxy's Singhs are $100M wealthier this year

The latest Forbes rich list showed the trials and travails of the globe's most wealthy: the number of billionaires on the planet dropped last year. But India's "pharmaceutical kings" Malvinder and Shivinder Singh--of Ranbaxy Laboratories fame--actually added $100 million to their combined net worth. Thank you, Daiichi Sankyo! Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.